ADA: Once-Weekly Tirzepatide Yields Lasting Weight Loss in Obesity

TUESDAY, June 7, 2022 -- For individuals with obesity, tirzepatide is associated with lasting weight loss, according to a study published online June 4 in the New England Journal of Medicine to coincide with the annual meeting of the American...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news